Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Valeo Pharma Inc VPHIF

Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler,... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Bullboard Posts (GREY:VPHIF)

Fourth Quarter and year-end 2023 Webcast and Conference Call

Valeo will host a conference call to discuss its fourth quarter and year-end 2023 results and highlights on Tuesday January 30...
Betteryear2 - January 29, 2024

VALEO PHARMA REPORTS RECORD ANNUAL REVENUES

Record revenues of $54 million for fiscal 2023, up 94% over 2022 Revenues of $13.1 million for Q4-23, up 4...
Betteryear2 - January 29, 2024

VPH

Interesting opportunityi high revenue high expenses. See where this sits next spring could be a nice play here at these levels
Bluechips19 - November 22, 2023

UPDATE ON OPHTHALMOLOGY BUSINESS UNIT T.VPH

Novartis agrees to sell global rights to XIIDRA® and several other ophthalmology products to Baucsh + Lomb SIMBRINZA®...
Betteryear2 - July 4, 2023

VALEO PHARMA REPORTS RECORD SECOND QUARTER REVENUES

VALEO PHARMA REPORTS RECORD SECOND QUARTER REVENUES - Valeo Pharma
NonoRobotSG - June 15, 2023

VPH: To profit from forest fires!

VPH sells products with a focus on Respiratory/Allergy.
Royal10 - June 6, 2023